Table of contents

Therapeutics

• Review: intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes (30 November, 2009) Free
• Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes (30 November, 2009)
• Minimally invasive and conventional glucose monitoring did not differ for long-term glycaemic control in insulin-treated diabetes (30 November, 2009)
• Once-only flexible sigmoidoscopy screening for colorectal cancer may not reduce colorectal cancer incidence or mortality (30 November, 2009)
• Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention (30 November, 2009)
• Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease (30 November, 2009)
• Paracetamol plus ibuprofen reduced fever in young children faster than paracetamol alone but not ibuprofen alone (30 November, 2009)
• Benefits of budesonide or nedocromil for mild to moderate asthma in children were not sustained after discontinuation (30 November, 2009)
• Review: exercise interventions reduce falls in elderly people living in the community (30 November, 2009)
• In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status (30 November, 2009)
• Both weight-bearing and non–weight-bearing exercise improved function in patients with knee osteoarthritis (30 November, 2009)
• Simulated acupuncture and real acupuncture both reduced low back pain dysfunction and symptoms (30 November, 2009)
• Review: evidence for the effectiveness of non-surgical interventions for low back pain and radiculopathy is limited (30 November, 2009)
• Review: evidence for the effectiveness of surgery for low back pain, radiculopathy, and spinal stenosis is limited (30 November, 2009)
• Review: erythropoiesis-stimulating agents increase mortality in patients with cancer (30 November, 2009)